The Regen Summit
Bringing together leading doctors of regenerative medicine to teach the products and strategies around running a modern practice.
theregensummit.comNews, Releases,and Resources
Company announcements from Vesalius Longevity Labs, and the conferences and summits where you can meet the team.
Press Releases
-
November 13, 2026Read the Release
Vesalius Longevity Labs Appoints Harvey Spevak as Chairman to Accelerate Global Growth and Brand Development
Vesalius Longevity Labs Inc. (CSE: VLAB) has appointed Harvey Spevak, Chairman of Equinox Group, as Chairman of its Board of Directors, effective November 13, 2026.
-
November 12, 2026Read the Release
Vesalius Longevity Labs Commences Trading Today on the Canadian Securities Exchange Under the Symbol “VLAB”
Vesalius Longevity Labs Inc. (CSE: VLAB) commenced trading on the Canadian Securities Exchange under the symbol “VLAB” today, November 12, 2026.
-
November 10, 2026Read the Release
Vesalius Longevity Labs Announces Commencement of Trading on the Canadian Securities Exchange Under the Symbol “VLAB”
Vesalius Longevity Labs Inc. (CSE: SE) (to trade as “VLAB”) will commence trading on the Canadian Securities Exchange under the symbol “VLAB” on November 12, 2026, further to its Listing Statement dated November 9, 2026.
-
November 9, 2026Read the Release
Vesalius Longevity Labs Closes Strategic Financing of US$6.5 Million, Led by Investor Group Organized by Harvey Spevak
Vesalius Longevity Labs Inc. (CSE: SE, to trade as “VLAB”) has completed a non-brokered private placement of 6,190,475 units at US$1.05 per Unit, for aggregate gross proceeds of US$6,499,998.75, led by an investor group organized by Harvey Spevak, Chairman of Equinox Group.
-
October 29, 2026Read the Release
Celularity and Vesalius Longevity Labs Sign Exclusive Collaboration for Peptual® Peptide APIs Manufactured in the United States
Celularity will serve as the exclusive partner for the finish manufacturing of Vesalius’s Peptual peptide APIs, establishing a United States final-stage API manufacturing and supply platform.
-
October 29, 2026Read the Release
Vesalius Announces Closing of Reverse Takeover Transaction
Vesalius Longevity Labs Inc. has closed its previously announced business combination with Vesalius Longevity Labs (Canada) Inc. and Vesalius Longevity Labs (SPV) Inc.
Conferences & Summits
PepMed 2026 | Regenerative Health World Congress
No organization combines clinical education, research, manufacturing, pharmacy, and legislative advocacy in a single peptide-focused event.
congress2026.pepmed.org
Please Note
Releases published on this page are company announcements. Content does not constitute medical advice, investment advice, or regulatory guidance.